Navigation Links
Effective Cancer Treatments Follow The Clock

colleagues used mice that genetically lack different components of the body's internal clock. “Knowing the molecular mechanism of internal clock function lets us make some important predictions of how these mice may respond to drug treatment,?said Antoch. “Thus, defects in Clock or Bmal1 genes, which essentially damp the cycles of the internal clock may produce very different effect when compared to defects in Cryptochrome gene, which, in contrast, `jams' the circadian clock at the most active point in its cycle.?/p>

Biological clocks function in the brain as well as lung, liver, heart and skeletal muscles. They operate on a 24-hour, circadian (Latin for "about a day") cycle that governs functions like sleeping and waking, rest and activity, fluid balance, body temperature, cardiac output, oxygen consumption and endocrine gland secretion.

In their experiments, the researchers measured the animals' body weight as an indicator of response to the anti-cancer drug. They discovered that Clock-mutant and Bmal1-knockout mice showed high sensitivity to the drug at any time it was administered ?as if the drug were administered early in the morning or late at night. In contrast, the Cryptochrome knockout mice showed more resistance to the drug at all times than did normal mice.

The researchers then tested whether this effect might be due to differences in the metabolic activation of the anti-cancer drug, but found essentially none. “This was a real surprise, because some of the enzymes involved in activating CY in the liver show circadian rhythms,?said Takahashi. “We thought that the liver might be activating the drug more strongly at some times, or detoxifying it less effectively, or both.?/p>

However, when the researchers analyzed the activity of the knockout animals' immune system B cells, they found evidence that the activity of the Clock and Bmal1 genes determined the cells' sensitivity to CY.

“Thus, this paper gives us specific mechanisti
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3

Related biology news :

1. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
2. FDA Works To Speed The Advent Of New, More Effective Personalized Medicines
3. Fungus Effective Against Winged Termites
4. NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
5. Effective, safe anthrax vaccine can be grown in tobacco plants
6. Effective HIV control may depend on viral protein targeted by immune cells
7. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
8. Jump-starting T Cells In Skin Cancer
9. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
10. Fox Chase Cancer Center scientists identify immune-system mutation
11. Breakthrough Microarray-based Technology for the Study of Cancer

Post Your Comments:
(Date:11/8/2009)...AYETTE, Ind. - Researchers at Purdue University ha... nerve fibers in spinal cord injuries using nano-s...ly after an accident. , The synthetic "copolymer...meters in diameter, or roughly 100 times smaller t...ers have been studying how to deliver drugs for ca...
(Date:11/6/2009)...ng ants generally live in harmony with their arbor...y run out of space in their trees of choice, the a...The research, published in the November issue of t... that ants bore into live trees, and it reopens a ...nts and plants. , Ants and certain species of pl...
(Date:11/5/2009)...University has been awarded a training grant in th...ndation under its Integrative Graduation Education...e first IGERT grant to be awarded to Kent State. T...ery and Reinvestment Act of 2009, runs through 201...es on environment aquatic resource sensing (EARS)....
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 1ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 3ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 4
...USA - Topics include: discovery of Sudbury impact...ersal of early modern humans out of Africa; relati... relationship of San Andreas fault system activity...cations of sediment mixing in studying the Great B...oseismology addresses earthquake prediction. The G...
...a, August 28, 2007 A new poisonous frog was recent...lombia by a team of young scientists supported by ...ew frog, which is almost two centimetres in length... Originally, the young scientists thought the frog...e area. However, after scientific analysis of the ...
...ished in the September 2007 issue of the Journal ...IGHLIGHTS , , , Renal transplant recipients ge...n use, New skin-healing chemicals, New anti-in... Understanding how obese fat cells work, , , , ... does not negatively impact fluvastatin use , Sci...
Other Biology News:September Geology and GSA Today media highlights 2September Geology and GSA Today media highlights 3September Geology and GSA Today media highlights 4September Geology and GSA Today media highlights 5September Geology and GSA Today media highlights 6September Geology and GSA Today media highlights 7September Geology and GSA Today media highlights 8September Geology and GSA Today media highlights 9September Geology and GSA Today media highlights 10September Geology and GSA Today media highlights 11September Geology and GSA Today media highlights 12Story ideas from the Journal of Lipid Research 2Story ideas from the Journal of Lipid Research 3Story ideas from the Journal of Lipid Research 4Story ideas from the Journal of Lipid Research 5
(Date:11/9/2009)...A, Va., Nov. 9 CEL-SCI C... Dr. Kenneth S. Rosenthal, Professor of Immunology...s College of Medicine and Pharmacy, reported on wo...he Cleveland Clinic and CEL-SCI on CEL-SCI,s LEAPS...e 7th GTCbio Vaccine: "All Things Considered" Conf...
(Date:11/8/2009)...UNTAIN VIEW, Calif. Nov. 5, 2009 Complete Genomi...pany, today announced publication of a report in t...A sequencing platform, including analysis of seque...nsumables cost for these three genomes sequenced o...nged from $8,005 for 87x coverage to $1,726 for 45...
(Date:11/6/2009)...Y, Mass., Nov. 6 Myriant Technolog...eloper and manufacturer of renewable bio-chemical...echnology provider Uhde GmbH, one of the world,s l...nnounced an alliance for the engineering, procurem... Succinic Acid plants based on renewable feedstock...
(Date:11/6/2009)...RD, Calif., Nov. 6 Intarcia Therap...its ITCA 650 (DUROS® continuous delivery of e...etes at the Ninth Annual Diabetes Technology Meeti...newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...e Via ITCA 650 Lowers Plasma Glucose, HbA1c and Re...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...d. NASA Goddard Space Flight Center in Greenbelt,...turing high-quality carbon nanotubes (CNT) has bee...fs Nano 50 awards in the Technology category. This...nner November 14 at the NASA Tech Briefs National ... Mass. , Judged by a panel of nanotechnology expe...
...change Symbol: MS, EDMONTON, Nov. 14 /PRNewswire-...ng developer in the treatment of multiple sclerosi...results for the third quarter, ended,September 30,...ain momentum towards the,commercialization of our ...sclerosis," said Kevin Giese, President and CEO of...
...., Nov. 14 MedPredict Market Research,a global pr...and market,research, has published a new report pr...biotech companies with a stake in the market for M... Thought Leader Insight & Analysis:,Multiple Scler...sies,emerging from ECTRIMS (European Committee for...
Other Biology Technology:NASA Goddard Space Flight Center's carbon nanotube manufacturing technology wins Nano 50 Award 2BioMS Medical announces third quarter 2007 results 2BioMS Medical announces third quarter 2007 results 3BioMS Medical announces third quarter 2007 results 4New Report Analyzes Key Controversies in Multiple Sclerosis Treatment 2
AGAROSE II (LOW MELT) from Pierce Biotechnology, Inc.
...antibody raised against a partial recombinant FES.... partial recombinant protein with GST tag. Prot...KYQEASKDKDRDKAKDKYVRSLWKLFAHHNRYVLGVRAAQLHHQHHHQLL...Accession: BC035357 Protein Accession Number: ...
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
Mouse Anti-Human PDE2A Monoclonal Antibody, Unconjugated, Clone 4F4 from Abnova Corporation
Biology Products: